Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Issuer Symbol
-
APRE on Nasdaq
There are no Buy or Sell transactions made by Michael Aaron Kelly since 14 Feb 2025
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
4,610 |
$16,969 |
$3.68 |
30 Jun 2021 |
Direct |
|
|
| Stock Option (Right to Buy) |
22,750 |
|
|
30 Jun 2021 |
Direct |
Common Stock |
|
Transactions reported by Michael Aaron Kelly for Aprea Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.